Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 25 of 2228 entries
View as:

Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02273466 Org: User:
Start: 02/28/02 End: - Due: -

A Study in Healthy Men to Test How BI 1810631 is Taken up and Processed by the Body

Phase: N/A Priority: Normal
NCT ID: NCT05879991 Org: User:
Start: 08/10/23 End: 10/19/23 Due: 10/19/24

BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01348347 Org: User:
Start: 04/25/11 End: 05/15/14 Due: 05/15/15

Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194777 Org: User:
Start: 06/30/01 End: - Due: -

Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT02642614 Org: User:
Start: 01/25/16 End: 06/14/16 Due: 06/14/17

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00153023 Org: User:
Start: 04/30/03 End: 12/31/05 Due: 12/31/06

Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02251197 Org: User:
Start: 07/31/01 End: - Due: -

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02177435 Org: User:
Start: 02/28/99 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02209688 Org: User:
Start: 02/29/00 End: - Due: -

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01778049 Org: User:
Start: 01/31/13 End: 03/31/15 Due: 03/31/16

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT02238314 Org: User:
Start: 01/31/99 End: - Due: -

BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour

Phase: N/A Priority: Normal
NCT ID: NCT00969761 Org: User:
Start: 08/31/09 End: 02/29/12 Due: 02/28/13

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02202512 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Phase: N/A Priority: Normal
NCT ID: NCT02337283 Org: User:
Start: 01/31/15 End: 11/30/15 Due: 11/30/16

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002368 Org: User:
Start: - End: - Due: -

Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02261129 Org: User:
Start: 09/30/08 End: - Due: -

A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06504862 Org: User:
Start: 08/20/24 End: 12/18/24 Due: 12/18/25

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02175342 Org: User:
Start: 03/01/98 End: - Due: -

Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02182635 Org: User:
Start: 08/31/98 End: - Due: -

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00168818 Org: User:
Start: 11/30/04 End: - Due: -

Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00855179 Org: User:
Start: 03/31/09 End: - Due: -

A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00710762 Org: User:
Start: 03/31/06 End: 03/31/14 Due: 03/31/15

Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01672788 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS

Phase: N/A Priority: Normal
NCT ID: NCT02265666 Org: User:
Start: 10/31/01 End: - Due: -

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Phase: N/A Priority: Normal
NCT ID: NCT02514174 Org: User:
Start: 08/18/15 End: 04/25/19 Due: 04/25/20